Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu
Phase 1
- Conditions
- Safety Issues
- First Posted Date
- 2018-12-28
- Last Posted Date
- 2018-12-28
- Lead Sponsor
- VA Pharma Limited Liability Company
- Target Recruit Count
- 54
- Registration Number
- NCT03789539
- Locations
- 🇷🇺
Research Institute of Influenza, Sankt-Petersburg, Saint-Petersburg, Russian Federation
News
No news found